Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 12/20 | 0.84 |
| ▸ | MMP9 | P14780 | 12/20 | 0.84 |
| ▸ | MMP13 | P45452 | 12/20 | 0.84 |
| ▸ | ADAM17 | P78536 | 12/20 | 0.84 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 2/20 | 0.42 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.42 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7348749 | 0.91 | MMP9 (1.00) | MMP1MMP9MMP13ADAM17 | |
| SCHEMBL7355486 | 0.91 | MMP9 (1.00) | MMP1MMP9MMP13ADAM17 | |
| SCHEMBL7554630 | 0.89 | MMP1 (0.78) | MMP1MMP9MMP13ADAM17GFER | |
| SCHEMBL7318146 | 0.89 | MMP1 (0.78) | MMP1MMP9MMP13ADAM17GFER | |
| SCHEMBL27563881 | 0.88 | MMP1 (0.65) | MMP1MMP9MMP13ADAM17GFER | |
| SCHEMBL7320044 | 0.82 | MMP1 (0.60) | MMP1MMP9MMP13ADAM17LTA4H | |
| SCHEMBL7316221 | 0.79 | MMP1 (0.81) | MMP1MMP9MMP13ADAM17GFER | |
| SCHEMBL27510260 | 0.77 | MMP1 (0.61) | MMP1MMP9MMP13ADAM17GFER | |
| SCHEMBL27511019 | 0.76 | KEAP1 (0.57) | MMP1MMP9MMP13ADAM17GFER | |
| SCHEMBL7348743 | 0.75 | MMP13 (0.70) | MMP1MMP9MMP13ADAM17LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0938471-B1 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | AMERICAN CYANAMID CO (US) | 2001-12-12 | — | — | EP | disclosed |
| EP-0938471-A1 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | American Cyanamid Company (US) | 1999-09-01 | — | — | EP | disclosed |
| US-5929097-A | INHIBIT TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME | AMERICAN CYANAMID COMPANY (US) | 1999-07-27 | — | — | US | disclosed |
| WO-1998016503-A2 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1998-04-23 | — | — | WO | disclosed |